View Older Stories View More Recent Stories

Jun 11, 2015 06:59AM Roth Capital Cuts Price Target on Quicksilver (ZQK) Following 2Q15 Results
Jun 10, 2015 02:50PM Roth Sees Peregrine Pharma (PPHM) Entering Key Execution Phase; Affirms at 'Buy'
Jun 10, 2015 08:48AM Roth Capital Raises Price Target on Radiant Logistics (RLGT) Following Announced Acquisitions
Jun 10, 2015 07:03AM RCA HGB-208 Pushback Seen as 'Modest Stumble', Roth Capital Says
Jun 10, 2015 06:39AM Roth Capital Remains Bullish on Craft Brewers Alliance (BREW) Following Investor Meetings
Jun 9, 2015 10:36AM Notable Analyst Rating Changes 6/9: (ECR) (AMED) (NBL) Upgraded; (CTXS) (ALV) (AKAM) Downgraded
Jun 9, 2015 10:32AM Draft Guidance From FDA 'Potentially Supportive' of Sarepta (SRPT) Accelerated Approval, Roth Capital Says
Jun 9, 2015 09:01AM Roth Capital Reiterates Bullish View on bluebird bio (BLUE) Ahead of EHA Data
Jun 9, 2015 08:42AM Roth Capital Upgrades QLT Inc (QLTI) to Buy
Jun 8, 2015 01:35PM Ballard Power (BLDP) $10M China Bus Deal Lays Foundation for Similar Deals, Roth Capital Says
Jun 8, 2015 11:02AM InSite Vision to Merge With Canadian Biotechnology Company QLT
Jun 8, 2015 09:31AM Roth Capital 'Impressed' with '6972 Safety Profile; Affirms Ligand Pharma (LGND) at 'Buy'
Jun 8, 2015 09:00AM Enphase Energy to Participate at Upcoming ROTH Capital Partners Conference
Jun 8, 2015 08:56AM Roth Capital Reiterates Buy Ahead of Vical (VICL) HSV-2 Data
Jun 8, 2015 08:00AM Cachet Financial Solutions Completes $4.4 Million Private Placement
Jun 8, 2015 07:58AM Sarepta Therapeutic (SRPT) Highlighted at Roth Capital as DMD-Sector Heats Up Into Summer
Jun 8, 2015 07:44AM Roth Capital Trims PT on Yingli Green Energy (YGE) to $1.30 Following Q1 Report
Jun 5, 2015 09:38AM Atossa Genetics (ATOS) Announces $6.22 Common Stock, Warrants Direct Placement
Jun 5, 2015 09:36AM Atossa Genetics Inc. to Raise Approximately $6,220,000 From Institutional Healthcare Investors
Jun 5, 2015 08:40AM Roth Capital Raised Price Target Following Ligand Pharma (LGND) Receipt of Milestone Payment
Jun 5, 2015 08:37AM Roth Capital Downgrades Zumiez, Inc. (ZUMZ) to Neutral
Jun 5, 2015 07:57AM Positive FDA Committee Vote on Flibanserin Bodes Well for Palatin's (PTN) Bremelanotide - Roth Capital
Jun 5, 2015 06:24AM Roth Capital Starts Mad Catz Interactive (MCZ) at Buy
Jun 4, 2015 10:21AM Notable Analyst Rating Changes 6/4: (CAVM) (T) (FTR) Upgraded; (TWTR) (DDS) (VZ) Downgraded
Jun 4, 2015 08:47AM Roth Capital Maintains Buy Rating on Pixelworks (PXLW) Following Asus Design Win
Jun 4, 2015 06:26AM Roth Capital Starts Coeur d'Alene Mines (CDE) at Buy
Jun 4, 2015 06:00AM Sky-mobi Announces Appointment of New Independent Director
Jun 3, 2015 03:21PM Detwiler Fenton Group Adds Investment Banking
Jun 3, 2015 03:13PM Roth Capital Assumes Dot Hill (HILL) at Buy
Jun 3, 2015 10:39AM Celator Pharmaceuticals (CPXX) Phase III Induction CR/CRi Data 'Major Catalyst', Roth Capital Says
Jun 3, 2015 10:00AM Notable Mergers and Acquisitions 6/3: (STCK) (URRE) (BABA)
Jun 3, 2015 09:28AM Uranium Resources (URRE), Anatolia Energy to Merge
Jun 3, 2015 09:25AM Uranium Resources and Anatolia Energy Announce Merger with Aim to Fast-Track Uranium Production
Jun 3, 2015 09:21AM Roth Capital Cuts Price Target on ReneSola (SOL) Following Q1 Miss and Weak Guidance
Jun 3, 2015 09:10AM Roth Capital Maintains Buy on Power Solutions (PSIX) Following a Revised Outlook
Jun 3, 2015 08:50AM ReneSola (SOL) Plans to Wind Down OEM Operations; Roth Affirms at 'Neutral' Following Q1 Results, Outlook
Jun 3, 2015 08:16AM Roth Capital Maintains Bullish View on uniQure BV (QURE) Ahead of Data; Sees as Potential Takeout Candidate
Jun 2, 2015 05:11PM Roth 'Encouraged' by Progress in Phase II GANNET53; Reaffirms Synta (SNTA) at 'Buy'
Jun 2, 2015 03:37PM Notable 52-Week Highs and Lows 6/2: (ETFC) (RXDX) (AER) High; (OGE) (CZR) Low
Jun 2, 2015 10:22AM Notable Analyst Rating Changes 6/2: (GFI) (ZION) (BUD) Upgraded; (ALTR) (IRM) (ITC) Downgraded
Jun 2, 2015 09:30AM Pre-Open Stock Movers 06/02: (AVEO) (VICL) (TA) Higher; (SOL) (TUBE) (RGLS) Lower (more...)
Jun 2, 2015 08:39AM Roth Capital Starts Cogentix Medical (CGNT) at Neutral
Jun 2, 2015 07:41AM Roth Capital Remains Bullish on Curis (CRIS) Following '907 Presentation at ASCO
Jun 2, 2015 06:17AM Roth Capital Starts Vical (VICL) at Buy; $4.65 PT
Jun 2, 2015 06:15AM Roth Capital Starts Evolution Petroleum (EPM) at Buy
Jun 1, 2015 02:14PM Roth Affirms Vascular Biogenics (VBLT) at 'Buy' Following VB-111 in rGBM Update; Phase 3 Study is 'Well Designed'
Jun 1, 2015 07:23AM Roth Capital Reiterates Buy on Pacific Ethanol (PEIX) Following Proposed Ethanol RVOs
Jun 1, 2015 07:20AM CTI BioPharma (CTIB) Pacritinib a Real Threat to Ruxolitinib, Roth Capital Says
Jun 1, 2015 07:17AM Roth Capital Bullish on Green Plains (GPRE) Following Proposed Ethanol RVOs
May 29, 2015 11:00AM Power Solutions International to Present at Upcoming Investor Conferences
View More Recent Stories View Older Stories